Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Expression of the plasmodial pfmdr1 gene in mammalian cells is associated with increased susceptibility to chloroquine.
van Es HH
,
Karcz S
,
Chu F
,
Cowman AF
,
Vidal S
,
Gros P
,
Schurr E
.
???displayArticle.abstract???
Chloroquine (CQ)-resistant (CQR) Plasmodium falciparum malaria parasites show a strong decrease in CQ accumulation in comparison with chloroquine-sensitive parasites. Controversy exists over the role of the plasmodial pfmdr1 gene in the CQR phenotype. pfmdr1 is a member of the superfamily of ATP-binding cassette transporters. Other members of this family are the mammalian multidrug resistance genes and the CFTR gene. We have expressed the pfmdr1-encoded protein, Pgh1, in CHO cells and Xenopus oocytes. CHO cells expressing the Pgh1 protein demonstrated an increased, verapamil-insensitive susceptibility to CQ. Conversely, no increase in drug susceptibility to primaquine, quinine, adriamycin, or colchicine was observed in Pgh1-expressing cells. CQ uptake experiments revealed an increased, ATP-dependent accumulation of CQ in Pgh1-expressing cells over the level in nonexpressing control cells. The increased CQ accumulation in Pgh1-expressing cells coincided with an enhanced in vivo inhibition of lysosomal alpha-galactosidase by CQ. CHO cells expressing Pgh1 carrying two of the CQR-associated Pgh1 amino acid changes (S1034C and N1042D) did not display an increased CQ sensitivity. Immunofluorescence experiments revealed an intracellular localization of both mutant and wild-type forms of Pgh1. We conclude from our results that wild-type Pgh1 protein can mediate an increased intracellular accumulation of CQ and that this function is impaired in CQR-associated mutant forms of the protein. We speculate that the Pgh1 protein plays an important role in CQ import in CQ-sensitive malaria parasites.
Awad-el-Kariem,
Chloroquine-resistant Plasmodium falciparum isolates from the Sudan lack two mutations in the pfmdr1 gene thought to be associated with chloroquine resistance.
1992, Pubmed
Awad-el-Kariem,
Chloroquine-resistant Plasmodium falciparum isolates from the Sudan lack two mutations in the pfmdr1 gene thought to be associated with chloroquine resistance.
1992,
Pubmed
Barasch,
Defective acidification of intracellular organelles in cystic fibrosis.
1991,
Pubmed
Barnes,
Selection for high-level chloroquine resistance results in deamplification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum.
1992,
Pubmed
Bray,
Rapid chloroquine efflux phenotype in both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. A correlation of chloroquine sensitivity with energy-dependent drug accumulation.
1992,
Pubmed
Cain,
Growth inhibition of 3T3 fibroblasts by lysosomotropic amines: correlation with effects on intravesicular pH but not vacuolation.
1986,
Pubmed
Castillo,
Functional expression of murine multidrug resistance in Xenopus laevis oocytes.
1990,
Pubmed
,
Xenbase
Chomczynski,
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
1987,
Pubmed
Cornwell,
Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein.
1987,
Pubmed
Cornwell,
ATP-binding properties of P glycoprotein from multidrug-resistant KB cells.
1987,
Pubmed
De Groot,
Inactivation by chloroquine of alpha-galactosidase in cultured human skin fibroblasts.
1981,
Pubmed
Devault,
Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities.
1990,
Pubmed
Endicott,
The biochemistry of P-glycoprotein-mediated multidrug resistance.
1989,
Pubmed
Ferrari,
Simulation of kinetic data on the influx and efflux of chloroquine by erythrocytes infected with Plasmodium falciparum. Evidence for a drug-importer in chloroquine-sensitive strains.
1991,
Pubmed
Foote,
Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum.
1990,
Pubmed
Foote,
Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum.
1989,
Pubmed
Gill,
Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein.
1992,
Pubmed
Ginsburg,
Kinetic modelling of chloroquine uptake by malaria-infected erythrocytes. Assessment of the factors that may determine drug resistance.
1991,
Pubmed
Goldberg,
The pathway of hemoglobin degradation in malaria parasites.
1992,
Pubmed
Groen,
An evaluation of the metabolite indicator method for determining the cytosolic phosphate potential in rat liver cells.
1982,
Pubmed
Gros,
Lipophilic cations: a group of model substrates for the multidrug-resistance transporter.
1992,
Pubmed
Hammond,
Enhanced efflux of [3H]vinblastine from Chinese hamster ovary cells transfected with a full-length complementary DNA clone for the mdr1 gene.
1989,
Pubmed
Higgins,
ABC transporters: from microorganisms to man.
1992,
Pubmed
Karcz,
Nucleotide binding properties of a P-glycoprotein homologue from Plasmodium falciparum.
1993,
Pubmed
Karcz,
Similarities and differences between the multidrug resistance phenotype of mammalian tumor cells and chloroquine resistance in Plasmodium falciparum.
1991,
Pubmed
Kaufman,
Identification of the components necessary for adenovirus translational control and their utilization in cDNA expression vectors.
1985,
Pubmed
Krogstad,
The basis of antimalarial action: non-weak base effects of chloroquine on acid vesicle pH.
1987,
Pubmed
Krogstad,
Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance.
1987,
Pubmed
Krogstad,
Energy dependence of chloroquine accumulation and chloroquine efflux in Plasmodium falciparum.
1992,
Pubmed
Lemontt,
Increased mdr gene expression and decreased drug accumulation in multidrug-resistant human melanoma cells.
1988,
Pubmed
Martin,
Reversal of chloroquine resistance in Plasmodium falciparum by verapamil.
1987,
Pubmed
Oude Elferink,
ATP-dependent efflux of GSSG and GS-conjugate from isolated rat hepatocytes.
1990,
Pubmed
Safa,
Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil.
1988,
Pubmed
Safa,
Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug-resistant cells.
1986,
Pubmed
Schurr,
Characterization of the multidrug resistance protein expressed in cell clones stably transfected with the mouse mdr1 cDNA.
1989,
Pubmed
Slater,
Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites.
1992,
Pubmed
Trager,
Human malaria parasites in continuous culture.
1976,
Pubmed
van Es,
Chemotherapy of malaria: a battle against all odds?
1993,
Pubmed
Veignie,
The mode of action of chloroquine. Non-weak base properties of 4-aminoquinolines and antimalarial effects on strains of Plasmodium.
1991,
Pubmed
Wellems,
Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross.
1990,
Pubmed
Wigler,
DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.
1979,
Pubmed
Wilson,
Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand.
1993,
Pubmed
